Publications

Targeting CXCR4 as a therapeutic strategy to improve outcomes in a mouse model of early chronic obstructive pulmonary disease (COPD)

Publié en mars 2022 Airway pharmacology and treatment
mars 2022

Targeting CXCR4 as a therapeutic strategy to improve outcomes in a mouse model of early chronic obstructive pulmonary disease (COPD)

Airway pharmacology and treatment
Publication précédente
mars 2022

TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension

Airway pharmacology and treatment
Publication suivante

Auteurs

  • Isabelle Dupin
    Pauline Henrot
    Elise Maurat
    Edmée Eyraud
    Pauline Esteves
    Maeva Zysman
    Marilyne Campagnac
    Marielle Dubreuil
    Guillaume Cardouat
    Clément Bouchet
    Olga Ousova
    Thomas Trian
    Véronique Freund-Michel
    Patrick Berger